Eiger BioPharmaceuticals (Patent Right of Avexitide) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Eiger BioPharmaceuticals (Patent Right of Avexitide) General Information

Description

Patent rights for drug discovery based in Palo Alto, California.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Palo Alto, CA
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Palo Alto, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eiger BioPharmaceuticals (Patent Right of Avexitide) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Eiger BioPharmaceuticals (Patent Right of Avexitide)‘s full profile, request access.

Request a free trial

Eiger BioPharmaceuticals (Patent Right of Avexitide) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Eiger BioPharmaceuticals (Patent Right of Avexitide)‘s full profile, request access.

Request a free trial

Eiger BioPharmaceuticals (Patent Right of Avexitide) FAQs

  • Where is Eiger BioPharmaceuticals (Patent Right of Avexitide) headquartered?

    Eiger BioPharmaceuticals (Patent Right of Avexitide) is headquartered in Palo Alto, CA.

  • What industry is Eiger BioPharmaceuticals (Patent Right of Avexitide) in?

    Eiger BioPharmaceuticals (Patent Right of Avexitide)’s primary industry is Buildings and Property.

  • Is Eiger BioPharmaceuticals (Patent Right of Avexitide) a private or public company?

    Eiger BioPharmaceuticals (Patent Right of Avexitide) is a Private company.

  • What is the current valuation of Eiger BioPharmaceuticals (Patent Right of Avexitide)?

    The current valuation of Eiger BioPharmaceuticals (Patent Right of Avexitide) is .

  • What is Eiger BioPharmaceuticals (Patent Right of Avexitide)’s current revenue?

    The current revenue for Eiger BioPharmaceuticals (Patent Right of Avexitide) is .

  • Who are Eiger BioPharmaceuticals (Patent Right of Avexitide)’s investors?

    Eiger BioPharmaceuticals has invested in Eiger BioPharmaceuticals (Patent Right of Avexitide).

  • When was Eiger BioPharmaceuticals (Patent Right of Avexitide) acquired?

    Eiger BioPharmaceuticals (Patent Right of Avexitide) was acquired on 09-Jul-2024.

  • Who acquired Eiger BioPharmaceuticals (Patent Right of Avexitide)?

    Eiger BioPharmaceuticals (Patent Right of Avexitide) was acquired by Amylyx Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process